Ten Capital Wealth Advisors’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,000
| Closed | -$1.37K | – | 643 |
|
|
2022
Q4 | $1.37K | Buy |
1,000
+110
| +12% | +$151 | ﹤0.01% | 459 |
|
|
2022
Q3 | $1K | Buy |
890
+100
| +13% | +$112 | ﹤0.01% | 526 |
|
|
2022
Q2 | $1K | Hold |
790
| – | – | ﹤0.01% | 431 |
|
|
2022
Q1 | $1K | Buy |
790
+140
| +22% | +$177 | ﹤0.01% | 455 |
|
|
2021
Q4 | $1K | Buy |
650
+98
| +18% | +$151 | ﹤0.01% | 454 |
|
|
2021
Q3 | $1K | Buy |
552
+227
| +70% | +$411 | ﹤0.01% | 410 |
|
|
2021
Q2 | $1K | Buy |
325
+125
| +63% | +$385 | ﹤0.01% | 454 |
|
|
2021
Q1 | $0 | Buy |
+200
| New | – | ﹤0.01% | 392 |
|